Insulin degludec and liraglutide Subcutaneous and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Insulin degludec and liraglutide Subcutaneous and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide Subcutaneous-Moxifloxacin
- Insulin degludec and liraglutide Subcutaneous-Moxifloxacin (Systemic)
- Insulin degludec and liraglutide Subcutaneous-Moxifloxacin Hydrochloride
- Insulin degludec and liraglutide Subcutaneous-Moxifloxacin Injection
- Insulin degludec and liraglutide Subcutaneous-Moxifloxacin Intravenous
- Insulin degludec and liraglutide Subcutaneous-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Insulin degludec Subcutaneous
- Moxetumomab pasudotox-tdfk Intravenous-Insulin detemir
- Moxetumomab pasudotox-tdfk Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Moxetumomab pasudotox-tdfk Intravenous-Insulin Detemir (Vials)
- Moxetumomab pasudotox-tdfk Intravenous-Insulin detemir Subcutaneous
- Moxetumomab pasudotox-tdfk Intravenous-Insulin glargine